NEPHMICRO

Nephros, Inc.

HealthcareMedical - Instruments & Supplies
$3.41
$0.00(-3.94%)
52W$2.66
$6.42
Updated Jul 8, 02:00 AM
RSI57
RS Rating27/99
Beta0.96
Volatility93%
F-Score6/9
Mkt Cap$37M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Nephros, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 27), showing significant lag compared to the market leaders. Earnings contraction of 76% provides fundamental context to the price action. Investors should exercise caution due to high volatility (93% annualized), which requires wider risk management.

Relative Strength
27
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.96
vs S&P 500
MARKET
52W Position
20%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.36
50 SMA > 100 SMA$3.36
100 SMA > 150 SMA$3.83
150 SMA > 200 SMA$4.12

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$3.31+3.15%ABOVE
50 SMA$3.36+1.63%ABOVE
100 SMA$3.36+1.46%ABOVE
150 SMA$3.83-10.96%BELOW
200 SMA$4.12-17.21%BELOW

Price Performance

1D-3.9%
1W-4.5%
1M+0.6%
3M+22.7%
6M-33.9%
YTD-28.2%
1Y-16.4%
3Y+30.6%
52-Week Trading Range20% from low
$3.41
52W Low$2.66
52W High$6.42

Technical Indicators

RSI (14)NEUTRAL
56.6
305070
Setup ScoreCOOL
4/10
Base depth: 34.0%

Risk Profile

Beta
0.96
52W Vol
93%
ATR
$0.27
Max DD (1Y)
-52%

Volume Analysis

Today
5.3K
50D Avg
21.8K
Vol Ratio
0.24x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+180%
$0.02
Q3'25+76%
$0.03
Q4'25-83%
$0.01
Q1'26-76%
$0.01
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+25.46%
5 Years:+17.02%
3 Years:+23.50%
TTM:+23.25%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-6.49%

Stock Price CAGR

10 Years:+4.25%
5 Years:-18.77%
3 Years:+30.62%
1 Year:-16.42%

Return on Equity

10Y Avg:-50.4%
5Y Avg:-18.9%
3Y Avg:-1.6%
Last Year:7.7%

Key Metrics

Market Cap$37M
Gross Margin61.1%
Net Margin6.4%
Piotroski F-Score6/9

Frequently Asked Questions

Is NEPH in an uptrend right now?

NEPH has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is NEPH overbought or oversold?

NEPH's RSI (14) is 57. The stock is in neutral territory, neither overbought nor oversold.

Is NEPH outperforming the market?

NEPH has a Relative Strength (RS) Rating of 27 out of 99. NEPH is currently lagging the broader market.

Where is NEPH in its 52-week range?

NEPH is trading at $3.41, which is 53% of its 52-week high ($6.42) and 20% above its 52-week low ($2.66).

How volatile is NEPH?

NEPH has a Beta of 0.96 and 52-week volatility of 93%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.